Rx Medicare

Phosphagenics Limited (“Phosphagenics”) (ASX: POH; OTCQX: PPGNY) today announced positive results from a Phase 1B clinical study using the Company’s patented TPM? (Targeted Penetration Matrix) for the transdermal delivery of oxycodone…

Read More…

Related Posts

• NuPathe Reports Positive Phase III Results For Zelrix, A Novel Transdermal Patch For Acute Migraine
• Alkermes Announces Positive Results For Phase 1 Study Of New Drug Candidate For Treatment Of Opioid-Induced Constipation
• Winston Laboratories, Inc. Announces Positive Top-line Results Of Phase II Clinical Trial Of Civamide Patch
• AcelRx Announces Positive Results From A Phase 2 Study Of ARX-03, A Sufentanil/Triazolam NanoTab For Procedural Sedation, Anxiolysis & Analgesia
• Transdel Pharmaceuticals Announces Positive Phase 3 Study Results For Lead Topical Pain Drug Ketotransdel(R)
• AcelRx Announces Positive Phase 2 Results From A Study Of ARX-01 Sufentanil NanoTabs In Treating Post-Operative Pain
• Nektar Announces Positive Results From Phase 2 Study Of Oral NKTR-118 In Patients With Opioid-Induced Constipation (OIC)
• Baxter Presents Clinical Efficacy Results From Phase III Study Of Seasonal Flu Vaccine
• SciClone And Sigma-Tau Announce Additional Positive Results In Clinical Study Examining ZADAXIN’s Ability To Enhance Response To H1N1 Vaccine
• SciClone And Sigma-Tau Announce Positive Preliminary Results In Clinical Study Examining ZADAXIN’S Ability To Enhance Response To H1N1 Vaccine
• ImmuneRegen BioSciences(R) Reports Additional Positive Results From Study Of Homspera(R) In Treating Highly Pathogenic Influenza
• SinoFresh Nasal Spray Achieves Positive Results Against H1N1 (Swine Flu) Virus In Initial Pilot Animal Study
• Positive Phase IIb Results For GSK1838262 (XP13512) Reported For Neuropathic Pain Associated With Post-Herpetic Neuralgia
• Valeant Pharmaceuticals Announces Preliminary Results From Its Phase IIa Retigabine Study For The Treatment Of Postherpetic Neuralgia (PHN)
• Orexo Announces Positive Phase III Results For KW-2246 In Japan

Tags: oxycodone, patch, phase, phosphagenics, positive, results, study, transdermal

This entry was posted on Wednesday, February 3rd, 2010 at 4:02 pm and is filed under Analgesics Pain Migraine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.